Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | BACE1 | P56817 | 4/20 | 0.38 |
| ▸ | RORC | P51449 | 2/20 | 0.38 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | KLK7 | P49862 | 1/20 | 0.35 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.35 |
| ▸ | NAAA | Q02083 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ACE | P12821 | 1/20 | 0.34 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.34 |
| ▸ | ITGAV | P06756 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13748627 | 0.90 | MAPT (0.40) | SYKMAPTBACE1RORCHRH4 | |
| SCHEMBL4062356 | 0.87 | ATM (0.38) | MAPTRORCHRH4ATMNAAA | |
| SCHEMBL13748614 | 0.85 | SYK (0.43) | SYKMAPTBACE1RORCHRH4 | |
| SCHEMBL14491738 | 0.83 | ATM (0.37) | MAPTRORCHRH4ATMNAAA | |
| SCHEMBL14491748 | 0.82 | SYK (0.56) | SYKMAPTRORCATMKLK7 | |
| SCHEMBL4062785 | 0.80 | ATM (0.39) | MAPTRORCHRH4ATMNAAA | |
| SCHEMBL4058026 | 0.80 | POLB (0.34) | — | |
| SCHEMBL13748422 | 0.80 | SLC7A5 (0.31) | — | |
| SCHEMBL4067265 | 0.79 | SIGMAR1 (0.43) | MAPTATMNAAAL3MBTL1ACE | |
| SCHEMBL4059560 | 0.79 | ATM (0.42) | ATMNAAAACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7569676-B2 | Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2009-08-04 | — | — | US | disclosed |
| EP-1498415-B1 | Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs | ROCHE DIAGNOSTICS GMBH (DE) | 2007-06-27 | — | — | EP | disclosed |